At the recent MedTech World Singapore Roadshow, I had the privilege of joining Daniel Ting, Dario Heymann, PhD and moderator Shwen Gwee for a panel on "The Crossover We Thought We Won't Need: Generative AI in MedTech" - exploring how this technology is reshaping healthcare in both unexpected and surprising ways.
At Advanced MedTech, we're harnessing Gen AI across three key areas: digital community engagement, clinical therapeutics, and operational efficiencies. Our UroGPT™ platform for kidney stone patients exemplifies this approach, offering personalised, interactive conversations that engage patients whilst reducing urologists' follow-up workload.
The key to successful Gen AI adoption in healthcare lies in addressing the most pressing challenges in patient journeys and clinical workflows. This focus naturally drives adoption, benefiting both patients and physicians.
We also tackled the evolving regulatory landscape. At Advanced MedTech, we've adopted an agile approach that prioritises patient safety and ethics. UroGPT™, for instance, is designed to complement, not replace, healthcare providers' expertise leveraging Gen AI to enhance patient care whilst alleviating the burden on healthcare providers.
I'm grateful to Shwen, my fellow panelists and all the event attendees for their valuable insights. This experience reinforces my belief that we're entering a new era in healthcare – one where technology and human expertise can work in harmony to deliver better outcomes for our patients.
#MedTechWorld #GenerativeAI #HealthcareInnovation #AIinHealthcarewww.linkedin.com
